Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Working Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 9.592.403.704.532.56

What is the latest Working Capital/Sales ratio of MANKIND PHARMA ?

The latest Working Capital/Sales ratio of MANKIND PHARMA is 9.59 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20259.59
Mar20242.40
Mar20233.70
Mar20224.53
Mar20212.56

How is Working Capital/Sales of MANKIND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 9.59
299.58
Mar2024 2.4
-35.14
Mar2023 3.7
-18.32
Mar2022 4.53
76.95
Mar2021 2.56 -

Other Financial Ratios of MANKIND PHARMA


Compare Working Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹91,010.0 Cr -1.9% -6.8% -15.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,068.0 Cr -0.7% 7.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹171,847.0 Cr -0.1% -4.8% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,985.0 Cr 2.2% 6.3% 11.4% Stock Analytics
CIPLA ₹122,826.0 Cr -0.6% 1.2% NA Stock Analytics
DR REDDYS LABORATORIES ₹106,418.0 Cr 1.5% 6.4% 4.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.9%

-6.8%

-15.7%

SENSEX

0%

2.7%

6.8%


You may also like the below Video Courses